Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/497264]Researchers: Prof Kenneth Beagley (Principal investigator) , Prof Louise Hafner , Prof Peter Timms
Brief description Genital Chlamydia infections are the most common sexually transmitted infection in Australia with annual health costs of 90-160 million dollars. Infection rates in 15-29 olds are increasing at 15-20% per year. Antibiotics are currently the treatment of choice, however antibiotic resistance is increasing and most infections are asymptomatic and not treated in the absence of screening programs. This project aims to develop a genital Chlamydia vaccine using a combination of novel antigens.
Funding Amount $AUD 207,551.81
Funding Scheme NHMRC Development Grants
Notes Development Grant
- nhmrc : 497264
- PURL : https://purl.org/au-research/grants/nhmrc/497264
